BlackRock Fund Advisors’s DMK Pharmaceuticals DMK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$159K Buy
723
+15
+2% +$3.01K ﹤0.01% 3488
2016
Q3
$170K Sell
708
-4
-0.6% -$831 ﹤0.01% 3498
2016
Q2
$139K Buy
712
+141
+25% +$65K ﹤0.01% 3571
2016
Q1
$245K Sell
571
-46
-7% -$16.4K ﹤0.01% 3397
2015
Q4
$233K Buy
617
+17
+3% +$5.33K ﹤0.01% 3473
2015
Q3
$163K Sell
600
-16
-3% -$4.46K ﹤0.01% 3559
2015
Q2
$181K Buy
616
+75
+14% +$22.7K ﹤0.01% 3561
2015
Q1
$149K Buy
+541
New +$234K ﹤0.01% 3551

Other funds holding DMK

BlackRock Fund Advisors's DMK Position: Q4 2016 in Review

BlackRock Fund Advisors increased its DMK Pharmaceuticals (DMK) stake by 2.1% in Q4 2016, buying an estimated $3.01K and bringing the position to 723 shares worth $159K. The position accounts for ﹤0.01% of the portfolio, ranked #3488.

BlackRock Fund Advisors first reported a position in DMK in Q1 2015 and has held it in 8 quarters since. The position peaked at $245K in Q1 2016. 35 funds tracked by Wall St. Rank hold DMK as of Q4 2016.

  • BlackRock Fund Advisors held 723 shares of DMK Pharmaceuticals worth $159K as of Q4 2016.
  • BlackRock Fund Advisors bought 15 DMK Pharmaceuticals shares in Q4 2016, an estimated $3.01K.
  • DMK Pharmaceuticals made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3488 holding.
  • BlackRock Fund Advisors first reported a position in DMK Pharmaceuticals in Q1 2015 and has held it in 8 quarters since.
  • BlackRock Fund Advisors's DMK Pharmaceuticals position peaked at $245K in Q1 2016.
  • 35 funds tracked by Wall St. Rank held DMK Pharmaceuticals as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.